Form 4: Thermo Fisher Scientific Director Reports Acquisition of Phantom Stock Units

Director R. Alexandra Keith reports acquisition of phantom stock units in Thermo Fisher Scientific through a deferred compensation plan.

Summary

• On June 29, 2024, R. Alexandra Keith, a director of Thermo Fisher Scientific Inc., reported the acquisition of phantom stock units.
• The acquisition was made through the Issuer's Deferred Compensation Plan for Directors.
• A total of 56.51 phantom stock units were credited to the reporting person's account at a price of $553.00 per unit.
• Following the transaction, the director beneficially owns 833.23 derivative securities.
• These units are convertible into common stock on a 1-for-1 basis and are distributable as stock upon cessation of director service or a change of control.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of phantom stock units by a director suggests confidence in the company's future, but it's a routine transaction.

Positives

• The acquisition of phantom stock units by a director signals confidence in the company's future performance.
• The Deferred Compensation Plan for Directors aligns the interests of directors with those of shareholders.

Future Outlook

The phantom stock units are distributable as stock upon cessation of director service or a change of control, indicating a long-term alignment of interests.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors and their alignment with shareholder interests.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's long-term performance.

Key Dates